Clinical trials
Phase 1 Diabetes Mellitus, Type 2 trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Recruiting | 3 |
| Terminated | 2 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 3 |
| Galenicum Health | 2 |
| Montreal Heart Institute | 2 |
| Novo Nordisk A/S | 2 |
| 1Globe Health Institute | 1 |
| Boehringer Ingelheim | 1 |
| Bristol-Myers Squibb | 1 |
| Dr. B. Catharine. Craven | 1 |
| Dr. Paul F. Gratzer | 1 |
| GAAD Medical Research Institute Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 22 |
| Diabetes Mellitus | 5 |
| Diabetes Mellitus, Type 1 | 3 |
| Cardiovascular Diseases | 2 |
| Insulin Resistance | 2 |
| Metabolic Syndrome | 2 |
| Non-alcoholic Fatty Liver Disease | 2 |
| Obesity | 2 |
| Atherosclerosis | 1 |
| Hypercholesterolemia | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.